Meristem Family Wealth’s ResMed RMD Stock Holding History

Meristem Family Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-936	Closed	-$247K	–	425
2021 Q3	$247K	Buy	+936	New	+$256K	0.02%	350

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Meristem Family Wealth's RMD Position: Q4 2021 in Review

Meristem Family Wealth sold out of ResMed (RMD) in Q4 2021, closing a stake of 936 shares — an estimated $247K sold.

Meristem Family Wealth first reported a position in RMD in Q3 2021 and held it in 1 quarter. The position peaked at $247K in Q3 2021. 724 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

Meristem Family Wealth reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
Meristem Family Wealth sold 936 ResMed shares in Q4 2021, an estimated $247K.
Meristem Family Wealth first reported a position in ResMed in Q3 2021 and held it in 1 quarter.
Meristem Family Wealth's ResMed position peaked at $247K in Q3 2021.
724 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Meristem Family Wealth's 13F filing for Q4 2021, filed 10 Feb 2022.